DK1131087T4 - Lindring af prostatacancersymptomer - Google Patents

Lindring af prostatacancersymptomer

Info

Publication number
DK1131087T4
DK1131087T4 DK99958892T DK99958892T DK1131087T4 DK 1131087 T4 DK1131087 T4 DK 1131087T4 DK 99958892 T DK99958892 T DK 99958892T DK 99958892 T DK99958892 T DK 99958892T DK 1131087 T4 DK1131087 T4 DK 1131087T4
Authority
DK
Denmark
Prior art keywords
relief
bmp
prostate cancer
cancer symptoms
gdf
Prior art date
Application number
DK99958892T
Other languages
Danish (da)
English (en)
Other versions
DK1131087T3 (da
Inventor
Kuber T Sampath
Charles M Cohen
David C Rueger
Original Assignee
Stryker Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22704676&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1131087(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stryker Corp filed Critical Stryker Corp
Application granted granted Critical
Publication of DK1131087T3 publication Critical patent/DK1131087T3/da
Publication of DK1131087T4 publication Critical patent/DK1131087T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK99958892T 1998-11-13 1999-11-12 Lindring af prostatacancersymptomer DK1131087T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19123998A 1998-11-13 1998-11-13
PCT/US1999/026636 WO2000029012A2 (en) 1998-11-13 1999-11-12 Methods of alleviating cancer symptoms

Publications (2)

Publication Number Publication Date
DK1131087T3 DK1131087T3 (da) 2004-12-13
DK1131087T4 true DK1131087T4 (da) 2009-08-03

Family

ID=22704676

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99958892T DK1131087T4 (da) 1998-11-13 1999-11-12 Lindring af prostatacancersymptomer

Country Status (10)

Country Link
EP (2) EP1435243A3 (ja)
JP (2) JP4892131B2 (ja)
AT (1) ATE275416T1 (ja)
AU (1) AU1616700A (ja)
CA (1) CA2349038C (ja)
DE (1) DE69920033T3 (ja)
DK (1) DK1131087T4 (ja)
ES (1) ES2226467T5 (ja)
PT (1) PT1131087E (ja)
WO (1) WO2000029012A2 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026713A1 (de) * 2000-05-30 2001-12-06 Walter Sebald Mutein einer Kette eines Proteins aus der Superfamilie des Wachstumsfaktors TGF-beta
EP1487877B1 (en) * 2001-09-18 2010-10-27 Genentech, Inc. Compositions and methods for the diagnosis of tumors
AU2005230854A1 (en) * 2004-03-31 2005-10-20 Xencor, Inc BMP-7 variants with improved properties
ATE454474T1 (de) * 2004-08-10 2010-01-15 Cardiff Biolog Ltd Verfahren und kit zur prognose von brustkrebs
EP1802326A2 (en) * 2004-09-09 2007-07-04 Stryker Corporation Methods for treating bone tumors using bone morphogenic proteins
JP2008169116A (ja) * 2005-04-18 2008-07-24 Tokyo Medical & Dental Univ Ｂｍｐ−７を含む抗ｃ型肝炎ウイルス剤
WO2006125867A1 (en) 2005-05-27 2006-11-30 Bbs-Bioactive Bone Substitutes Oy Bone morphogenetic protein 4 and osteogenic devices and pharmaceutical products containing thereof
ATE533781T1 (de) 2005-05-27 2011-12-15 Bbs Bioactive Bone Substitutes Oy Heparin-bindungsstelle enthaltendes knochenmorphogenetisches protein 6 und osteogene vorrichtungen und pharmazeutische produkte, die diese enthalten
US7851435B2 (en) 2005-05-27 2010-12-14 Bbs-Bioactive Bone Substitutes Oy Bone morphogenetic protein 3 and osteogenic devices and pharmaceutical products containing thereof
DK3117833T3 (en) 2005-07-19 2019-03-18 Stemgen S P A Inhibition of Tumor-rich Potential of Tumor Stem Cells with LIF
GB0615129D0 (en) * 2006-07-29 2006-09-06 Univ Cardiff Anti-cancer activity of BMP-9 and BMP-10 and their use in cancer therapies

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399569B1 (en) * 1991-03-11 2002-06-04 Curis, Inc. Morphogen treatments for limiting proliferation of epithelial cells
US5652118A (en) † 1991-03-11 1997-07-29 Creative Biomolecules, Inc. Nucleic acid encoding a novel morphogenic protein, OP-3
DE69231946T2 (de) † 1991-03-11 2002-04-04 Curis Inc Protein-induzierende morphogenese
US6287816B1 (en) * 1991-06-25 2001-09-11 Genetics Institute, Inc. BMP-9 compositions
ES2201059T5 (es) † 1992-07-31 2007-11-01 Curis, Inc. Regeneracion y reparacion de nervios inducida por morfogenos.
JP4255986B2 (ja) * 1992-09-15 2009-04-22 ストライカー・コーポレーション 消化管潰瘍のモルフォゲン治療
WO1995030003A2 (en) † 1994-04-29 1995-11-09 Creative Biomolecules, Inc. Morphogenic protein-specific cell surface receptors and uses therefor
JPH08225454A (ja) * 1995-02-23 1996-09-03 Chugai Pharmaceut Co Ltd マイクロスフェア製剤
FR2737501B1 (fr) * 1995-07-31 1997-10-24 Transgene Sa Nouveaux virus auxiliaires pour la preparation de vecteurs viraux recombinants
US6379961B1 (en) † 1995-09-21 2002-04-30 The Trustees Of Columbia University In The City Of New York Uses of bone morphogenetic proteins
WO1998050061A1 (en) * 1997-05-07 1998-11-12 Biogen, Inc. Novel therapies for cystic kidney disease

Also Published As

Publication number Publication date
EP1131087A2 (en) 2001-09-12
JP2002529513A (ja) 2002-09-10
CA2349038A1 (en) 2000-05-25
JP2010150278A (ja) 2010-07-08
EP1131087B2 (en) 2009-04-01
AU1616700A (en) 2000-06-05
EP1435243A2 (en) 2004-07-07
DE69920033D1 (de) 2004-10-14
WO2000029012A3 (en) 2000-11-16
ES2226467T5 (es) 2009-08-27
CA2349038C (en) 2011-08-02
EP1435243A3 (en) 2005-02-09
DE69920033T3 (de) 2009-10-08
DE69920033T2 (de) 2005-09-22
EP1131087B1 (en) 2004-09-08
PT1131087E (pt) 2004-12-31
WO2000029012A2 (en) 2000-05-25
ATE275416T1 (de) 2004-09-15
JP4892131B2 (ja) 2012-03-07
WO2000029012A8 (en) 2001-01-11
DK1131087T3 (da) 2004-12-13
ES2226467T3 (es) 2005-03-16

Similar Documents

Publication Publication Date Title
Moan et al. The biophysical foundations of photodynamic therapy
DK1131087T4 (da) Lindring af prostatacancersymptomer
SE9900100D0 (sv) New compounds
CA2170700A1 (en) Pyrazolopyrimidines and Pyrrolopyrimidines for Treatment of Neuronal and Other Disorders
DE60121988D1 (de) Kombinationstherapie mit antidiabetischen und antikonvulsiven mitteln
AU6613896A (en) Chemical compounds
AU2001276689A1 (en) Novel remedies for cancer
DE60107234D1 (de) Antitubulinanordnung und zellenwachstumshemmstoff "dioxostatin"
MY124786A (en) Bis-arylsulfones
WO2000018439A3 (de) Verwendung von neoangiogenese-markern für diagnose und therapie von tumoren
BR0017157A (pt) Derivados de 6-hidroxi-indazol para o tratamento de glaucoma
CA2167004A1 (en) Agent for treating mental disorders associated with cerebrovascular disorders
DE60128100D1 (de) Analgetisches arzneimittel
NO20032762L (no) Aktivitetsstyringsanordning
TR199901017A2 (xx) B�cek ilac� terkibi.
IT1311132B1 (it) Corpo farfallato .
Font et al. Finding the words: Instruments for a therapy of liberation
AU2001291133A1 (en) Methods of decreasing or preventing pain using spicamycin derivatives
CA2153778A1 (en) Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
Coppola et al. Early retroduodenal perforation following endoscopic internal biliary drainage
DE69625210T2 (de) Nicorandil gegen angstneurosen
IT1302188B1 (it) Procedimento e dispositivo atti alla regolazione di una grandezzadi funzionamento di un veicolo.
CA2452432A1 (en) Active ingredient combination for the pharmacological therapy of nicotine dependence
TNSN00247A1 (fr) Combinaison de trimebutine avec un analgesique opioide .
ITBO970709A0 (it) Dispositivo per il comando dall'esterno di una serratura antipanico.